Table 2.
|
MAF (95% CI) |
|
|
---|---|---|---|
Control | Cases | p-Value | |
All | 44.0 (40.7, 47.3) | 44.9 (42.0, 47.8) | 0.7165 |
Female | 42.4 (37.7, 47.3) | 47.4 (44.1, 50.6) | 0.1032 |
Male | 45.2 (40.9, 49.7) | 33.5 (27.3, 40.3) | 0.0049 |
Anti-CCP positive | |||
All | 44.0 (40.7, 47.3) | 46.8 (43.3, 50.3) | 0.2555 |
Female | 42.4 (37.7, 47.3) | 49.5 (45.7, 53.4) | 0.0295 |
Male | 45.2 (40.9, 49.7) | 33.1 (25.6, 41.5) | 0.0128 |
Anti-CCP negative | |||
All | 44.0 (40.7, 47.3) | 42.8 (37.4, 48.4) | 0.7384 |
Female | 42.4 (37.7, 47.3) | 44.6 (38.5, 50.9) | 0.6214 |
Male | 45.2 (40.9, 49.7) | 35.9 (25.3, 48.2) | 0.1811 |
MAF, minor allele frequency; CI, confidence interval; CCP, cyclic citrullinated peptide.